Price target upside
Orchestra BioMed Holdings Price Target: +108.9% vs Current Price
Direct answer
Orchestra BioMed Holdings's analyst target implies +108.9%.
The average target is $12.43 compared with a recorded current price of $5.95.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked October 10, 2026.
Get free Orchestra BioMed Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $5.95
- Average price target
- $12.43
- High price target
- $20.00
- Low price target
- $9.00
- Low target gap
- +51.3%
- Target upside
- +108.9%
- High target gap
- +236.1%
- Target range width
- 184.9%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- October 10, 2026
- Valid through
- October 17, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Orchestra BioMed Holdings's average target imply?
Orchestra BioMed Holdings's average target is $12.43 versus a recorded price of $5.95. The difference is +108.9%.
How far are Orchestra BioMed Holdings's low and high targets from the recorded price?
The low target implies +51.3%, while the high target implies +236.1%.
How many analysts are included in Orchestra BioMed Holdings's consensus?
The verified consensus includes 7 analysts.
How is Orchestra BioMed Holdings's target upside or downside calculated?
The average target of $12.43 is divided by the recorded price of $5.95, then one is subtracted to produce +108.9%. This does not guarantee a future return.
When was Orchestra BioMed Holdings's analyst forecast verified?
The data was verified on 2026-10-10. The dataset is valid through 2026-10-17.